secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2023-05-31T23:59:59+00:00
Accession:  0001654954-23-007428
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv elects Irving Wiesen as Class I director at 2023 annual meeting
-------------------------------------------------------------------------------

- Irving Wiesen elected Class I director with 7,477,036 for and 11,696,947 withheld; 515,852 broker non-votes.
- Ratification of Crowe PR PSC as auditor for FY ending Oct 31, 2023 passed with 14,344,226 for, 1,492,688 against, 3,852,921 abstain.
- Withheld votes exceeded for votes in director election; elected by plurality rule.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495423007428/0001654954-23-007428-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495423007428/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-007428

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer